Back
Speaker illustration

Doctor Panagiotis Theofilis

Hippokration General Hospital, Athens (Greece)

Dr. Panagiotis Theofilis is a resident Cardiologist at the 1st Cardiology Department, "Hippocratio" G.H.A. He is a PhD candidate in the University of Athens Medical School and has been involved in research projects since 2017. His current research interests involve atherosclerosis and its associated risk factors, hypertension and the heart-kidney interaction, as well as the role of microRNAs in cardiovascular disease. He has authored more than 70 manuscripts published in international, peer-reviewed journals.

Presentations Articles

The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in epicardial adipose tissue modulation: a meta-analysis

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session: Diabetes, obesity, and the heart

Access
Like
Thumbnail

Baseline right ventricular-pulmonary artery uncoupling and mortality following transcatheter aortic valve replacement: a meta-analysis

Event: ESC Congress 2024

Topic: Aortic Valve Intervention

Session: TAVI: common and unusual complications and their management

Access
Like
Thumbnail

Changes in N-terminal pro b-type natriuretic peptide according to SGLT2 inhibitor utilization patterns in patients hospitalized for decompensated heart failure: a prospective cohort study

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Biomarkers in acute heart failure: latest findings

Access
Like
Thumbnail

PCSK9 inhibitors and coronary atherosclerotic plaque modification: a meta-analysis

Event: ESC Congress 2024

Topic: Treatment

Session: Lipid-lowering treatment: impact on the atherosclerotic plaque and outcomes

Access
Like
Thumbnail

The prognostic role of clinical features and biomarkers in patients hospitalized with cardiorenal syndromes

Event: ESC Congress 2023

Topic: Biomarkers

Session: Emerging evidence for biomarkers in heart failure

Access
Like
Thumbnail

The efficacy of coronary sinus reduction in refractory angina: A meta-analysis

Event: ESC Congress 2023

Topic: Nonpharmacological Treatment

Session: Risk stratification and treatment options in chronic coronary syndrome

Access
Like
Thumbnail

Prognostic significance of risk factors and biomarkers in patients hospitalized for cardiorenal syndromes

Event: Heart Failure 2022

Topic: Renal Failure and Cardiovascular Disease

Session: Heart Failure ePosters - focus on Comorbidities and special population

Access
Like
Thumbnail

The impact of SGLT2 inhibitors on indices of cardiac function: An updated systematic review and meta-analysis

Event: Heart Failure 2022

Topic: Antidiabetic Pharmacotherapy

Session: Modern technologies in heart failure

Access
Like
Thumbnail

MicroRNA-126 mimic administration accelerates vascular perfusion recovery and angiogenesis in a hind limb ischemia model

Event: ESC Congress 2021 - The Digital Experience

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Basic science e-posters

Access
Like
Thumbnail

The impact of diabetes mellitus on carotid atherosclerosis and arterial stiffness; results from the Corinthia study

Event: ESC Congress 2021 - The Digital Experience

Topic: Diabetes and the Heart

Session: Risk Factors and Prevention ePosters

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources